Search research articles
Contact Us
Filters
Showing results (61-70 of 75) with videos related to
Page
of 8
Sort By:
Foodborne Pathogens and Disease
|
June 30, 2018
Outbreak of Vibrio parahaemolyticus Associated with Consumption of Raw Oysters in Canada, 2015
Marsha Taylor, Joyce Cheng, Davendra Sharma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2020
Regulatory Considerations for Contribution of Effect of Drugs Used in Combination Regimens: Renal Cell Cancer Case Studies
Jamie R Brewer, Elaine Chang, Sundeep Agrawal, et al.
Journal of Pain and Symptom Management
|
August 3, 2023
"At the End I Have a Say": Engaging the Chinese Community in Advance Care Planning
Sarah Nouri, Lingsheng Li, Carrie Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 8, 2020
FDA Approval Summary: Lurbinectedin for the Treatment of Metastatic Small Cell Lung Cancer
Sonia Singh, Adnan A Jaigirdar, Flora Mulkey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2020
FDA Approval Summary: Accelerated Approval of Sacituzumab Govitecan-hziy for Third-line Treatment of Metastatic Triple-negative Breast Cancer
Sakar Wahby, Lola Fashoyin-Aje, Christy L Osgood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2018
U.S. Food and Drug Administration Approval: Neratinib for the Extended Adjuvant Treatment of Early-Stage HER2-Positive Breast Cancer
Harpreet Singh, Amanda J Walker, Laleh Amiri-Kordestani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 8, 2023
FDA Approval Summary: Futibatinib for Unresectable Advanced or Metastatic, Chemotherapy Refractory Intrahepatic Cholangiocarcinoma with FGFR2 Fusions or Other Rearrangements
Shruti U Gandhy, Sandra J Casak, Sirisha L Mushti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 15, 2020
FDA Approval Summary: Tucatinib for the Treatment of Patients with Advanced or Metastatic HER2-positive Breast Cancer
Mirat Shah, Suparna Wedam, Joyce Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2016
FDA Approval: Uridine Triacetate for the Treatment of Patients Following Fluorouracil or Capecitabine Overdose or Exhibiting Early-Onset Severe Toxicities Following Administration of These Drugs
Gwynn Ison, Julia A Beaver, W David McGuinn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2016
U.S. Food and Drug Administration Approval: Cabozantinib for the Treatment of Advanced Renal Cell Carcinoma
Harpreet Singh, Michael Brave, Julia A Beaver, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 75) with videos related to
Sort By:
Page
of 8
Foodborne Pathogens and Disease
|
June 30, 2018
Outbreak of Vibrio parahaemolyticus Associated with Consumption of Raw Oysters in Canada, 2015
Marsha Taylor, Joyce Cheng, Davendra Sharma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2020
Regulatory Considerations for Contribution of Effect of Drugs Used in Combination Regimens: Renal Cell Cancer Case Studies
Jamie R Brewer, Elaine Chang, Sundeep Agrawal, et al.
Journal of Pain and Symptom Management
|
August 3, 2023
"At the End I Have a Say": Engaging the Chinese Community in Advance Care Planning
Sarah Nouri, Lingsheng Li, Carrie Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 8, 2020
FDA Approval Summary: Lurbinectedin for the Treatment of Metastatic Small Cell Lung Cancer
Sonia Singh, Adnan A Jaigirdar, Flora Mulkey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2020
FDA Approval Summary: Accelerated Approval of Sacituzumab Govitecan-hziy for Third-line Treatment of Metastatic Triple-negative Breast Cancer
Sakar Wahby, Lola Fashoyin-Aje, Christy L Osgood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2018
U.S. Food and Drug Administration Approval: Neratinib for the Extended Adjuvant Treatment of Early-Stage HER2-Positive Breast Cancer
Harpreet Singh, Amanda J Walker, Laleh Amiri-Kordestani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 8, 2023
FDA Approval Summary: Futibatinib for Unresectable Advanced or Metastatic, Chemotherapy Refractory Intrahepatic Cholangiocarcinoma with FGFR2 Fusions or Other Rearrangements
Shruti U Gandhy, Sandra J Casak, Sirisha L Mushti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 15, 2020
FDA Approval Summary: Tucatinib for the Treatment of Patients with Advanced or Metastatic HER2-positive Breast Cancer
Mirat Shah, Suparna Wedam, Joyce Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2016
FDA Approval: Uridine Triacetate for the Treatment of Patients Following Fluorouracil or Capecitabine Overdose or Exhibiting Early-Onset Severe Toxicities Following Administration of These Drugs
Gwynn Ison, Julia A Beaver, W David McGuinn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2016
U.S. Food and Drug Administration Approval: Cabozantinib for the Treatment of Advanced Renal Cell Carcinoma
Harpreet Singh, Michael Brave, Julia A Beaver, et al.
Page
of 8